ITBO910112A0 - Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari - Google Patents

Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari

Info

Publication number
ITBO910112A0
ITBO910112A0 IT91BO112A ITBO910112A ITBO910112A0 IT BO910112 A0 ITBO910112 A0 IT BO910112A0 IT 91BO112 A IT91BO112 A IT 91BO112A IT BO910112 A ITBO910112 A IT BO910112A IT BO910112 A0 ITBO910112 A0 IT BO910112A0
Authority
IT
Italy
Prior art keywords
gastro
pharmaceutical formulations
oral use
bile acids
use containing
Prior art date
Application number
IT91BO112A
Other languages
English (en)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann filed Critical Alfa Wassermann
Publication of ITBO910112A0 publication Critical patent/ITBO910112A0/it
Priority to ITBO910112A priority Critical patent/IT1245889B/it
Priority to US07/861,461 priority patent/US5302398A/en
Priority to DE69212882T priority patent/DE69212882T2/de
Priority to ES92105714T priority patent/ES2090394T3/es
Priority to DK92105714.7T priority patent/DK0510404T3/da
Priority to EP92105714A priority patent/EP0510404B1/en
Priority to TW081102516A priority patent/TW202389B/zh
Priority to JP4091129A priority patent/JP2509044B2/ja
Priority to CA002065809A priority patent/CA2065809C/en
Priority to KR1019920006051A priority patent/KR970005175B1/ko
Publication of ITBO910112A1 publication Critical patent/ITBO910112A1/it
Application granted granted Critical
Publication of IT1245889B publication Critical patent/IT1245889B/it
Priority to GR960402160T priority patent/GR3020843T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITBO910112A 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari. IT1245889B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITBO910112A IT1245889B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
US07/861,461 US5302398A (en) 1991-04-12 1992-04-01 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
TW081102516A TW202389B (it) 1991-04-12 1992-04-02
ES92105714T ES2090394T3 (es) 1991-04-12 1992-04-02 Formulados farmaceuticos gastroresistentes para administracion oral conteniendo sales de acidos biliares.
DK92105714.7T DK0510404T3 (da) 1991-04-12 1992-04-02 Gastroresistente farmaceutiske formuleringer til oral administration indeholdende galdesyresalte
EP92105714A EP0510404B1 (en) 1991-04-12 1992-04-02 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
DE69212882T DE69212882T2 (de) 1991-04-12 1992-04-02 Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
JP4091129A JP2509044B2 (ja) 1991-04-12 1992-04-10 胆汁酸塩を含有する胃液耐性のある経口投与用製剤
CA002065809A CA2065809C (en) 1991-04-12 1992-04-10 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
KR1019920006051A KR970005175B1 (ko) 1991-04-12 1992-04-11 담즙산의 염을 함유하는 경구용 위내성 의약 포뮬레이션
GR960402160T GR3020843T3 (en) 1991-04-12 1996-08-22 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910112A IT1245889B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.

Publications (3)

Publication Number Publication Date
ITBO910112A0 true ITBO910112A0 (it) 1991-04-12
ITBO910112A1 ITBO910112A1 (it) 1992-10-12
IT1245889B IT1245889B (it) 1994-10-25

Family

ID=11337388

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO910112A IT1245889B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.

Country Status (11)

Country Link
US (1) US5302398A (it)
EP (1) EP0510404B1 (it)
JP (1) JP2509044B2 (it)
KR (1) KR970005175B1 (it)
CA (1) CA2065809C (it)
DE (1) DE69212882T2 (it)
DK (1) DK0510404T3 (it)
ES (1) ES2090394T3 (it)
GR (1) GR3020843T3 (it)
IT (1) IT1245889B (it)
TW (1) TW202389B (it)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0640344T3 (da) * 1993-08-30 1999-07-05 Medichemie Ag Ursodesoxycholsyreholdigt lægemiddel i flydende administreringsform
KR100578669B1 (ko) * 1997-05-29 2006-12-07 동아제약주식회사 우르소데옥시콜린산을함유하는투명연질캅셀
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
AU758679B2 (en) 1998-07-24 2003-03-27 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
DE19906290A1 (de) * 1999-02-15 2000-08-17 Falk Pharma Gmbh Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
FR2796271B1 (fr) 1999-07-15 2002-01-11 Oreal Composition sans cire structuree sous forme rigide par un polymere
FR2796272B1 (fr) 1999-07-15 2003-09-19 Oreal Composition sans cire structuree sous forme rigide par un polymere
DE60019541T2 (de) * 1999-12-28 2006-03-09 L'oreal Strukturierte langhaltige Zubereitung enthaltend ein Polymer und pastöse Fettstoffe
FR2804018B1 (fr) * 2000-01-24 2008-07-11 Oreal Composition sans transfert structuree sous forme rigide par un polymere
RU2277913C2 (ru) * 2000-02-04 2006-06-20 Сео Хонг Ю Получение водного прозрачного раствора лекарственных форм с желчными кислотами
JP2002034198A (ja) * 2000-07-18 2002-01-31 Minebea Co Ltd スピンドルモータ
US6835399B2 (en) * 2000-12-12 2004-12-28 L'ORéAL S.A. Cosmetic composition comprising a polymer blend
US8080257B2 (en) * 2000-12-12 2011-12-20 L'oreal S.A. Cosmetic compositions containing at least one hetero polymer and at least one film-forming silicone resin and methods of using
WO2002047623A1 (en) * 2000-12-12 2002-06-20 L'oreal Sa Composition comprising at least one heteropolymer and at least one inert filler and methods for use
US7276547B2 (en) * 2000-12-12 2007-10-02 L'oreal S.A. Compositions comprising heteropolymers and at least one oil-soluble polymers chosen from alkyl celluloses and alkylated guar gums
US6881400B2 (en) * 2000-12-12 2005-04-19 L'oreal S.A. Use of at least one polyamide polymer in a mascara composition for increasing the adhesion of and/or expressly loading make-up deposited on eyelashes
FR2817739B1 (fr) * 2000-12-12 2005-01-07 Oreal Composition cosmetique coloree transparente ou translucide
WO2002047630A1 (fr) * 2000-12-12 2002-06-20 L'oreal Composition cosmetique comprenant un melange de polymeres
AU2002256544A1 (en) * 2000-12-12 2002-06-24 L'oreal Sa Cosmetic compositions containing at least one heteropolymer and at least one gelling agent and methods of using the same
US20020168335A1 (en) * 2000-12-12 2002-11-14 Nathalie Collin Cosmetic composition comprising a wax and a polymer
US20020107314A1 (en) * 2000-12-12 2002-08-08 Carlos Pinzon Compositions containing heteropolymers and oil-soluble esters and methods of using same
AU2001220877A1 (en) * 2000-12-12 2002-06-24 L'oreal S.A. Cosmetic composition comprising heteropolymers and a solid substance and method of using same
FR2817740B1 (fr) * 2000-12-12 2006-08-04 Oreal Procede de fabrication d'une composition cosmetique coloree de maquillage a transmittance controlee
WO2002047628A1 (en) * 2000-12-13 2002-06-20 L'oréal Composition structured with a polymer containing a heteroatom and an organogelator
FR2819400B1 (fr) * 2001-01-15 2004-12-03 Oreal Composition cosmetique de maquillage ou de soin des matieres keratiniques comprenant un melange de polymeres
US7025953B2 (en) * 2001-01-17 2006-04-11 L'oreal S.A. Nail polish composition comprising a polymer
FR2819399B1 (fr) * 2001-01-17 2003-02-21 Oreal Composition cosmetique contenant un polymere et une huile fluoree
US6897205B2 (en) * 2001-01-31 2005-05-24 Roehm Gmbh & Co. Kg Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
US6716420B2 (en) * 2001-10-05 2004-04-06 L′Oreal Methods of use and of making a mascara comprising at least one coloring agent and at least one heteropolymer
FR2832060B1 (fr) * 2001-11-09 2004-07-09 Oreal Composition contenant un ester n-acyle d'acide amine et un filtre uv structuree par un polyamide
US6927071B2 (en) * 2001-12-07 2005-08-09 Beckman Coulter, Inc. Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma
US20080057011A1 (en) * 2001-12-12 2008-03-06 L'oreal S.A., Composition structured with a polymer containing a heteroatom and an Organogelator
US20040247549A1 (en) * 2002-06-12 2004-12-09 L'oreal S.A. Cosmetic emulsions containing at least one hetero polymer and at least one sunscreen and methods of using the same
US20050008598A1 (en) 2003-07-11 2005-01-13 Shaoxiang Lu Cosmetic compositions comprising a structuring agent, silicone powder and swelling agent
US7008629B2 (en) * 2002-07-22 2006-03-07 L'ORéAL S.A. Compositions comprising at least one heteropolymer and fibers, and methods of using the same
US20040166133A1 (en) * 2003-01-21 2004-08-26 L'oreal Method of making a mascara composition comprising polyamide polymer and at least one solid substance having a melting point of 45oC or greater
US20040241252A1 (en) * 2003-05-29 2004-12-02 Abney Christopher Charles Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
US20040261311A1 (en) * 2003-06-13 2004-12-30 Mike Mattlage Fishing hook
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
WO2006026555A2 (en) * 2004-08-30 2006-03-09 Seo Hong Yoo Neuroprotective effect of solubilized udca in focal ischemic model
DE602005027727D1 (de) * 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
WO2006050165A2 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
US8865197B2 (en) * 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
KR101512624B1 (ko) * 2008-02-20 2015-04-16 그노시스 에스.피.에이. 폴레이트, 이의 조성물 및 용도
WO2010080730A2 (en) * 2009-01-09 2010-07-15 Mayo Foundation For Medical Education And Research Methods and materials for delivering bile acids
ES2835874T3 (es) * 2014-07-29 2021-06-23 Shenzhen Hightide Biopharmaceutical Ltd Sales de berberina, sales ursodesoxicólicas y combinaciones, procedimientos de preparación y aplicación de las mismas
CN110898036A (zh) * 2019-12-18 2020-03-24 乐普制药科技有限公司 一种熊去氧胆酸缓释肠溶胶囊及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
IT1212141B (it) * 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
US5047258A (en) * 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process

Also Published As

Publication number Publication date
GR3020843T3 (en) 1996-11-30
CA2065809A1 (en) 1992-10-13
ES2090394T3 (es) 1996-10-16
KR920019358A (ko) 1992-11-19
US5302398A (en) 1994-04-12
IT1245889B (it) 1994-10-25
KR970005175B1 (ko) 1997-04-14
JPH0597678A (ja) 1993-04-20
CA2065809C (en) 1999-01-12
EP0510404A1 (en) 1992-10-28
EP0510404B1 (en) 1996-08-21
DE69212882T2 (de) 1997-01-23
JP2509044B2 (ja) 1996-06-19
ITBO910112A1 (it) 1992-10-12
TW202389B (it) 1993-03-21
DE69212882D1 (de) 1996-09-26
DK0510404T3 (da) 1996-09-09

Similar Documents

Publication Publication Date Title
ITBO910112A0 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
ITBO910114A0 (it) Formulazioni farmaceutiche a rilascio controllato per uso orale ga- stroresistenti contenenti acidi biliari e loro sali
ITMI931324A1 (it) Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
DK0585252T3 (da) Farmaceutiske formuleringer
ATE219377T1 (de) Neue galenische orale pharmazeutische formulierung
DK0814797T3 (da) Parenterale farmaceutiske præparater indeholdende alkylammoniumsalte fra 2-arylpropionsyrer
IT8420940A0 (it) Sali stabili della solfo-adenosil-l-metionina (same)particolarmente idonei per uso farmaceutico orale.
ITMI931326A0 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
EE03744B1 (et) Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
ITMI921445A1 (it) Sali del glutatione etilestere
ITFI910003A0 (it) Procedimento per la preparazione di acidi difosfonici e loro sali
IT8821965A0 (it) Composizioni farmaceutiche orali contenenti sali di destrorfano.
DE69624992T2 (de) Pharmazeutische Zusammensetzungen zum topischen Gebrauch enthaltend Ketoprofen
FI941566A (fi) Suun kautta annettava trimetoprim-liuos
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
IT1219704B (it) Sali di glicosaminoglicani,procedimento per la loro preparazione e relative composizioni farmaceutiche
ITMI920317A1 (it) Composizioni farmaceutiche per uso orale a base di glutatione ridotto
IT8419554A0 (it) Base di aminoacidi formulazione farmaceutica orale a
ITMI911065A0 (it) Sali ad attivita' antiinfiammatoria, antisettica, detergente e composizioni farmaceutiche
ITTO910279A1 (it) Procedimento per la preparazione dell'acido -metil-4-(2-metilpropil) benzeneacetico e dei suoi sali
FI941696A (fi) Systeemi lääkkeen oraaliseen antoon

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960307